BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
4D Molecular Therapeutics
FDMT
$609M
| $38.8M | ﹤0.01% |
1,438,363
+706,953
| +97% | +$20.2M |
|
2827
Arrow Financial
AROW
$723M
| $38.6M | ﹤0.01% |
1,192,911
-22,678
| -2% | -$744K |
|
|
EPZM
2828
DELISTED
Epizyme, Inc
EPZM
| $38.6M | ﹤0.01% |
7,544,359
-287,661
| -4% | -$1.75M |
|
|
RSX
2829
DELISTED
VanEck Russia ETF
RSX
| $38.6M | ﹤0.01% |
1,273,716
-303,954
| -19% | -$8.88M |
|
2830
Alight
ALIT
$394M
| $38.5M | ﹤0.01% |
+167,760
| New | +$35.4M |
|
2831
Ribbon Communications
RBBN
$377M
| $38.5M | ﹤0.01% |
6,431,005
-155,573
| -2% | -$1.05M |
|
2832
iShares MSCI Intl Quality Factor ETF
IQLT
$14.3B
| $38.3M | ﹤0.01% |
1,011,920
+126,499
| +14% | +$5M |
|
2833
Amerant Bancorp
AMTB
$1.14B
| $38.3M | ﹤0.01% |
1,549,258
-35,535
| -2% | -$839K |
|
2834
W&T Offshore
WTI
$546M
| $38.3M | ﹤0.01% |
10,290,646
+1,604,736
| +18% | +$5.73M |
|
2835
GSK
GSK
$101B
| $38.2M | ﹤0.01% |
799,816
+63,114
| +9% | +$3.17M |
|
2836
FS KKR Capital
FSK
$3.49B
| $38.1M | ﹤0.01% |
1,726,449
+968,566
| +128% | +$21.4M |
|
2837
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.33B
| $38M | ﹤0.01% |
998,737
+149,762
| +18% | +$5.88M |
|
|
SPNE
2838
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $38M | ﹤0.01% |
2,415,642
+13,132
| +0.5% | +$225K |
|
2839
Verastem
VSTM
$604M
| $38M | ﹤0.01% |
1,027,510
+12,880
| +1% | +$473K |
|
2840
Phathom Pharmaceuticals
PHAT
$743M
| $38M | ﹤0.01% |
1,182,878
+22,441
| +2% | +$746K |
|
2841
Nkarta
NKTX
$165M
| $37.9M | ﹤0.01% |
1,361,219
+8,393
| +0.6% | +$266K |
|
2842
NRC Health Common Stock
NRC
$471M
| $37.8M | ﹤0.01% |
896,008
-14,717
| -2% | -$741K |
|
2843
Theravance Biopharma
TBPH
$878M
| $37.8M | ﹤0.01% |
5,104,459
+583,752
| +13% | +$6.53M |
|
|
FLIC
2844
DELISTED
First of Long Island Corp
FLIC
| $37.8M | ﹤0.01% |
1,833,430
-39,821
| -2% | -$837K |
|
2845
Hackett Group
HCKT
$277M
| $37.7M | ﹤0.01% |
1,922,937
-17,025
| -0.9% | -$319K |
|
|
VAPO
2846
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $37.6M | ﹤0.01% |
211,028
+4,725
| +2% | +$960K |
|
2847
CALL
FedEx
FDX
$80.3B
| $37.5M | ﹤0.01% |
171,200
-31,800
| -16% | -$8.63M |
|
2848
State Street Energy Select Sector SPDR ETF
XLE
$39.9B
| $37.4M | ﹤0.01% |
1,437,458
-612,922
| -30% | -$15.2M |
|
2849
BioAtla
BCAB
$5.73M
| $37.4M | ﹤0.01% |
25,414
+3,578
| +16% | +$6.97M |
|
|
ACBI
2850
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $37.4M | ﹤0.01% |
1,412,189
-33,249
| -2% | -$811K |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.